Sterling Financial Planning, Inc. Pfizer Inc Transaction History

Sterling Financial Planning, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$41.32 - $61.25 $100,738 - $149,327	-2,438 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$39.25 - $50.42 $269,412 - $346,082	-6,864 Reduced 73.79%	2,438 $105,000
Q2 2021 Aug 02, 2021	SELL	$35.91 - $40.68 $50,130 - $56,789	-1,396 Reduced 13.05%	9,302 $364,000
Q1 2021 Apr 28, 2021	BUY	$33.49 - $37.77 $84,428 - $95,218	2,521 Added 30.83%	10,698 $388,000
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $273,684 - $348,013	8,177 New	8,177 $301,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Sterling Financial Planning, Inc., based on Form 13F filings with the SEC.

Stay updated on Sterling Financial Planning, Inc. with notifications on news.